TY  - GEN
AU  - Yang,Hwai-I
AU  - Yeh,Ming-Lun
AU  - Wong,Grace L
AU  - Peng,Cheng-Yuan
AU  - Chen,Chien-Hung
AU  - Trinh,Huy N
AU  - Cheung,Ka-Shing
AU  - Xie,Qing
AU  - Su,Tung-Hung
AU  - Kozuka,Ritsuzo
AU  - Lee,Dong-Hyun
AU  - Ogawa,Eiichi
AU  - Zhao,Changqing
AU  - Ning,Hui-Bin
AU  - Huang,Rui
AU  - Li,Jiayi
AU  - Zhang,Jian Q
AU  - Ide,Tatsuya
AU  - Xing,Huichun
AU  - Iwane,Shinji
AU  - Takahashi,Hirokazu
AU  - Wong,Christopher
AU  - Wong,Clifford
AU  - Lin,Chia-Hsin
AU  - Hoang,Joseph
AU  - Le,An
AU  - Henry,Linda
AU  - Toyoda,Hidenori
AU  - Ueno,Yoshiyuki
AU  - Gane,Edward J
AU  - Eguchi,Yuichiro
AU  - Kurosaki,Masayuki
AU  - Wu,Chao
AU  - Liu,Chenghai
AU  - Shang,Jia
AU  - Furusyo,Norihiro
AU  - Enomoto,Masaru
AU  - Kao,Jia-Horng
AU  - Yuen,Man-Fung
AU  - Yu,Ming-Lung
AU  - Nguyen,Mindie H
TI  - Real-World Effectiveness From the Asia Pacific Rim Liver Consortium for HBV Risk Score for the Prediction of Hepatocellular Carcinoma in Chronic Hepatitis B Patients Treated With Oral Antiviral Therapy
SN  - 1537-6613
PY  - 2020///0921
KW  - Administration, Oral
KW  - Adult
KW  - Antiviral Agents
KW  - administration & dosage
KW  - Asia
KW  - ethnology
KW  - Asian People
KW  - Carcinoma, Hepatocellular
KW  - etiology
KW  - Cohort Studies
KW  - DNA, Viral
KW  - genetics
KW  - Data Accuracy
KW  - Female
KW  - Hepatitis B virus
KW  - Hepatitis B, Chronic
KW  - drug therapy
KW  - Humans
KW  - Liver Neoplasms
KW  - Male
KW  - Middle Aged
KW  - Proportional Hazards Models
KW  - ROC Curve
KW  - Random Allocation
KW  - Research Design
KW  - Risk Assessment
N1  - Publication Type: Journal Article; Research Support, Non-U.S. Gov't; Validation Study
UR  - https://doi.org/10.1093/infdis/jiz477
ER  -